A Case Study of a Mid-Size Pharmaceutical Company's Biostatistics and Data Management Group with NDA Submissions: Past, Recent and Future-- Biostatistics and Data Management Committee
Wed, August 22 12:00 pm – 2:00 pm
When: Wednesday, August 22, 2007
Time: 12:00-2:00 PM
Where: MBC Office, One Cambridge Center, 9th Floor, Cambridge, MA
Overview:
Cubist Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing antiinfective therapies for the acute care environment. Cubist has reengineered its biostatistics and data management processes to be more efficient, streamlined, and scalable to meet the evolving data and regulatory standards for a New Drug Application (NDA) since its first approval in 2003 and recent sNDA approval in 2006. Changes include development of Biostatistics and Data Management focused operational guidelines and procedures, implementation of CDISC and moving from eNDA to the eCTD format. Come hear about Cubist’s journey, the lessons learned and current plans for future submissions
Speakers:
Jameelah Aziz- Sr. Manager, Clinical Data Management, Cubist Pharmaceuticals
Ted Trost- Manager, Regulatory Information Systems, Cubist Pharmaceuticals
We look forward to seeing you there!
Lunch will be served.
|
email your name, title and company to register@massbio.org. Please include "BDM 8/22" in the subject line. |
For more information on Membership, contact Lori Gold at lori.gold@massbio.org or 617-674-5149. |




PHONE: 617.674.5100
EMAIL: